To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene C10orf119TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
406 supporting clones for gene C10orf119 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
AL515935 brain, neuroblastoma, neuroblastoma cells .a 1 to 1019 1 to 1008       1008/1076
(93 %)
20 diff
(98.2 %id)
BX457599 neuroblastoma .a 1 to 698 1 to 698   tiling clone,   698/698
(100 %)
0 diff
(100 %id)
CN259319 embryonic stem cells, DMSO-treated H9 cellline .a 86 to 235 1 to 150       150/150
(100 %)
2 diff
(98.7 %id)
BM464245 leiomyosarcoma, uterus .a 89 to 665 24 to 602       579/1225
(47 %)
11 diff
(99.2 %id)
NM_024834.2   .a 89 to 4329 1 to 4241 exact RefSeq,   4241/4241
(100 %)
0 diff
(100 %id)
BM451450 eye, retinoblastoma .a 97 to 961 1 to 868       868/970
(89 %)
23 diff
(97.7 %id)
CX752415 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 97 to 799 1 to 689     Submitted on the opposite strand 689/743
(92 %)
21 diff
(97.2 %id)
AL518068 brain, neuroblastoma, neuroblastoma cells .a 98 to 1114 1 to 1007       1007/1007
(100 %)
38 diff
(96.3 %id)
BX424020 neuroblastoma .a 98 to 967 1 to 868       868/868
(100 %)
6 diff
(99.4 %id)
BQ438029 leiomyosarcoma, uterus .a 98 to 816 1 to 722       722/885
(81 %)
9 diff
(99.0 %id)
BU902327 leiomyosarcoma, uterus .a 104 to 1113 1 to 1013       1013/1112
(91 %)
22 diff
(98.1 %id)
AW410333 muscle, rhabdomyosarcoma .a 117 to 700 20 to 604     Possibly primed on the genome, locally A rich (37/37 A in genome downstream of last aligned base) 585/604
(96 %)
6 diff
(99.1 %id)
BE889780 leiomyosarcoma, uterus .a 117 to 815 1 to 697       697/747
(93 %)
11 diff
(98.6 %id)
CV573430 cornea, eye .a 123 to 733 1 to 611       611/611
(100 %)
1 diff
(99.9 %id)
TI_57186599   .a 124 to 850 52 to 789       709/739
(95 %)
27 diff
(96.4 %id)
BI856972 breast, mammary adenocarcinoma, cell line .a 125 to 850 1 to 737       708/738
(95 %)
27 diff
(96.4 %id)
BQ436253 melanotic melanoma, skin .a 125 to 670 1 to 549       549/1099
(49 %)
18 diff
(98.4 %id)
CV809850 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 125 to 819 1 to 696       696/701
(99 %)
21 diff
(97.1 %id)
CN259314 embryonic stem cells, DMSO-treated H9 cellline .a 130 to 583 1 to 454       454/454
(100 %)
3 diff
(99.4 %id)
BG683129 brain, neuroblastoma, cell line .a 130 to 815 1 to 692       665/692
(96 %)
27 diff
(96.1 %id)
BQ072134 brain, neuroblastoma, cell line .a 132 to 970 1 to 852       852/1080
(78 %)
25 diff
(97.7 %id)
CN259316 embryonic stem cells, cell lines H1, H7, andH9 .a 134 to 261 1 to 128       128/128
(100 %)
1 diff
(99.3 %id)
BQ926018 large cell carcinoma, lung .a 134 to 418 1 to 285       285/778
(36 %)
1 diff
(99.9 %id)
TI_57240147   .a 134 to 781 26 to 686       661/691
(95 %)
27 diff
(96.1 %id)
CN259312 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 135 to 379 1 to 245       245/245
(100 %)
4 diff
(98.4 %id)
CN259320 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 136 to 289 1 to 154       154/154
(100 %)
2 diff
(98.8 %id)
BM461866 leiomyosarcoma, uterus .a 139 to 807 1 to 671       671/932
(71 %)
18 diff
(98.1 %id)
BM463902 melanotic melanoma, skin .a 139 to 937 1 to 801       801/1094
(73 %)
22 diff
(98.0 %id)
BQ070305 brain, neuroblastoma, cell line .a 139 to 672 1 to 533       533/1026
(51 %)
24 diff
(97.7 %id)
BI916670 brain .a 140 to 781 1 to 655       655/660
(99 %)
29 diff
(95.7 %id)
BQ231534 embryonal carcinoma, cell line, testis .a 140 to 816 1 to 679       679/887
(76 %)
2 diff
(99.8 %id)
BQ230194 epithelioid carcinoma, Pancreas .a 140 to 920 1 to 791       791/867
(91 %)
14 diff
(98.4 %id)
CF138541 lymph .a 141 to 639 1 to 499       499/499
(100 %)
5 diff
(99.0 %id)
CN259318 embryonic stem cells, cell lines H1, H7, andH9 .a 148 to 405 1 to 258       258/258
(100 %)
1 diff
(99.7 %id)
TI_154168527   .a 148 to 795 95 to 747       653/884
(73 %)
13 diff
(98.6 %id)
CA394329 eye, RPE/choroid .a 150 to 769 1 to 620       620/620
(100 %)
3 diff
(99.6 %id)
CN259311 embryonic stem cells, cell lines H1, H7, andH9 .a 152 to 660 1 to 509       509/509
(100 %)
2 diff
(99.7 %id)
BE561984 Burkitt lymphoma, lymph .a 158 to 861 27 to 740       682/1185
(57 %)
28 diff
(97.7 %id)
BQ894757 eye, normal pigmented retinal epithelium .a 166 to 672 1 to 507       507/1313
(38 %)
5 diff
(99.7 %id)
BX358477 Placenta Cot 25-normalized .a 176 to 1214 1 to 1038       1038/1038
(100 %)
2 diff
(99.9 %id)
BF514239   .a 190 to 517 338 to 11   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 328/346
(94 %)
0 diff
(100 %id)
AK023143   .a 217 to 4329 1 to 4113 exact tiling clone, available from FLJ,   4113/4113
(100 %)
2 diff
(100.0 %id)
DN991352 brain, whole brain .a 217 to 930 1 to 714       714/714
(100 %)
6 diff
(99.2 %id)
BI559507 testis .a 265 to 911 7 to 655       649/655
(99 %)
11 diff
(98.4 %id)
TI_44348160   .a 265 to 911 84 to 732       649/732
(88 %)
11 diff
(98.5 %id)
CN259321 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 269 to 1009 12 to 753       742/753
(98 %)
7 diff
(99.1 %id)
DA025370   .a 281 to 845 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DA657090   .a 301 to 871 2 to 572   capped   571/571
(100 %)
1 diff
(99.9 %id)
BE546476 cervical carcinoma cell line, cervix .a 379 to 968 1 to 597       597/662
(90 %)
25 diff
(96.3 %id)
TI_1948154635   .a 387 to 1339 123 to 1068   fully sequenced,   946/1068
(88 %)
25 diff
(97.7 %id)
BX501670 Liver .a 396 to 966 1 to 571       571/571
(100 %)
2 diff
(99.7 %id)
BU428690 lymph .a 396 to 809 1 to 414       414/414
(100 %)
3 diff
(99.3 %id)
TI_154149544   .a 399 to 899 74 to 574       501/501
(100 %)
4 diff
(99.3 %id)
Z25249 leg muscle, skeletal muscle .a 405 to 713 1 to 307       307/310
(99 %)
8 diff
(97.5 %id)
AA305344 colon .a 503 to 831 1 to 329       329/329
(100 %)
0 diff
(100 %id)
AW962355   .a 504 to 1073 1 to 573       573/573
(100 %)
16 diff
(97.3 %id)
DA226661 brain .a 512 to 1061 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
BG250670 adenocarcinoma, cell line, Liver .a 568 to 1228 1 to 662       662/943
(70 %)
15 diff
(98.5 %id)
DA805059 brain .a 583 to 1121 2 to 541   capped   540/540
(100 %)
2 diff
(99.7 %id)
CV575264 cornea, eye .a 586 to 1196 1 to 611       611/611
(100 %)
0 diff
(100 %id)
BG168174 hypernephroma, cell line, Kidney .a 606 to 1332 1 to 723       723/742
(97 %)
14 diff
(98.2 %id)
N55732   .a 619 to 876 9 to 265       257/265
(96 %)
8 diff
(97.0 %id)
BP332244 renal proximal tubule .a 652 to 1230 1 to 579       579/579
(100 %)
1 diff
(99.9 %id)
BF515266   .a 661 to 1163 18 to 519     Submitted on the opposite strand 502/502
(100 %)
2 diff
(99.7 %id)
BE905489 epithelioid carcinoma, Pancreas .a 715 to 1392 1 to 672       672/862
(77 %)
20 diff
(97.7 %id)
BM466027 embryonal carcinoma, cell line, testis .a 720 to 1722 1 to 1022       1022/1109
(92 %)
41 diff
(96.4 %id)
CF135175 CNCAP(3)T-225 cell line, Prostate .a 744 to 1292 9 to 557       549/557
(98 %)
8 diff
(98.6 %id)
TI_154163421   .a 744 to 1505 80 to 861       708/817
(86 %)
27 diff
(96.7 %id)
BP351264   .a 828 to 1409 1 to 581       581/581
(100 %)
2 diff
(99.7 %id)
R61472 whole brain .a 973 to 1352 1 to 384     Possibly primed on the genome, locally A rich (37/37 A in genome downstream of last aligned base) 384/388
(98 %)
8 diff
(98.0 %id)
CN259328 embryonic stem cells, cell lines H1, H7, andH9 .a 985 to 1242 1 to 258       258/258
(100 %)
1 diff
(99.7 %id)
AA092014   .a 1086 to 1245 1 to 160       160/161
(99 %)
4 diff
(97.6 %id)
AA095955   .a 1091 to 1301 1 to 210       210/212
(99 %)
7 diff
(96.7 %id)
EC454185 Prostate .a 1094 to 1176 83 to 1       83/89
(93 %)
2 diff
(97.8 %id)
EC455581 Prostate .a 1094 to 1176 83 to 1       83/89
(93 %)
2 diff
(97.8 %id)
EC486195 Prostate .a 1094 to 1176 83 to 1       83/89
(93 %)
2 diff
(97.8 %id)
R17805 whole brain .a 1103 to 1576 1 to 485       464/485
(95 %)
20 diff
(95.9 %id)
R18745 whole brain .a 1103 to 1516 1 to 428       428/445
(96 %)
22 diff
(95.1 %id)
H11851 whole brain .a 1103 to 1495 1 to 394       394/394
(100 %)
1 diff
(99.8 %id)
R59054 whole brain .a 1104 to 1595 1 to 500       500/503
(99 %)
9 diff
(98.3 %id)
R59803 whole brain .a 1104 to 1516 1 to 415       415/431
(96 %)
3 diff
(99.4 %id)
H14424 whole brain .a 1104 to 1576 2 to 481       480/483
(99 %)
7 diff
(98.6 %id)
H19130 whole brain .a 1104 to 1481 2 to 380       379/497
(76 %)
2 diff
(99.6 %id)
H29435 whole brain .a 1104 to 1482 2 to 384       383/391
(97 %)
5 diff
(98.8 %id)
BP337967 Spleen .a 1120 to 1698 1 to 579       579/579
(100 %)
0 diff
(100 %id)
BF924661 nervous_tumor .a 1179 to 1561 1 to 383       383/383
(100 %)
3 diff
(99.3 %id)
BF377857 testis_normal .a 1188 to 1602 1 to 423       389/423
(91 %)
25 diff
(94.1 %id)
AW811797 stomach .a 1234 to 1540 308 to 1       308/317
(97 %)
14 diff
(95.6 %id)
BF374906 stomach .a 1241 to 1506 266 to 1       266/266
(100 %)
1 diff
(99.7 %id)
TI_1948154636   .a 1315 to 2314 1130 to 130   fully sequenced,   1001/1130
(88 %)
24 diff
(97.9 %id)
BG531281 embryonal carcinoma, testis .a 1378 to 2002 1 to 625       625/626
(99 %)
9 diff
(98.6 %id)
BE618245 eye, retinoblastoma .a 1397 to 2162 1 to 770       768/789
(97 %)
19 diff
(97.6 %id)
BC000935 Placenta, choriocarcinoma .a 1402 to 2590 1 to 1189   available from MGC, AAA Possibly primed on the genome, locally A rich (37/37 A in genome downstream of last aligned base) 1189/1189
(100 %)
0 diff
(100 %id)
BF570490 melanotic melanoma, high MDR, skin .a 1408 to 2076 1 to 667       667/668
(99 %)
24 diff
(96.5 %id)
BM752390 Ascites, stomach .a 1408 to 1688 1 to 281       281/281
(100 %)
1 diff
(99.7 %id)
CN259313 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 1419 to 1993 1 to 575       575/575
(100 %)
3 diff
(99.5 %id)
BE536123 cervix .a 1424 to 2190 1 to 769   available from MGC,   769/845
(91 %)
32 diff
(96.3 %id)
DB491479 hypothalamus .a 1438 to 1801 1 to 365       365/365
(100 %)
13 diff
(96.5 %id)
AL515934 brain, neuroblastoma, neuroblastoma cells .a 1441 to 2578 1122 to 1       1122/1147
(97 %)
27 diff
(97.7 %id)
AW811796 stomach .a 1442 to 1696 1 to 255       255/255
(100 %)
4 diff
(98.5 %id)
BG617578 Liver .a 1452 to 2225 1 to 781       781/785
(99 %)
13 diff
(98.4 %id)
EH333249   .a 1455 to 1512 1 to 58       58/58
(100 %)
0 diff
(100 %id)
BM807043 duodenal adenocarcinoma, cell line, small intestine .a 1474 to 2404 1 to 937       937/1030
(90 %)
7 diff
(99.4 %id)
CR609239 Neuroblastoma Cot 10-normalized .a 1517 to 3979 1 to 2463   tiling clone,   2463/2463
(100 %)
0 diff
(100 %id)
AL520231 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .a 1517 to 2449 1 to 932       932/937
(99 %)
4 diff
(99.6 %id)
EH336572   .a 1519 to 1597 1 to 79       79/79
(100 %)
1 diff
(98.8 %id)
BG679928 skin, squamous cell carcinoma .a 1533 to 2291 1 to 758       758/758
(100 %)
1 diff
(99.9 %id)
BI258182 cervical carcinoma cell line, cervix .a 1540 to 2469 1 to 926       926/988
(93 %)
42 diff
(95.8 %id)
BI089768 cervix .a 1545 to 2297 1 to 757       757/881
(85 %)
10 diff
(98.9 %id)
AA348799 adrenal gland .a 1547 to 1919 1 to 376       376/377
(99 %)
7 diff
(98.2 %id)
BG498654 adenocarcinoma, Prostate .a 1561 to 1997 248 to 680       433/680
(63 %)
10 diff
(98.6 %id)
BP378958 uterus .a 1561 to 2141 1 to 581       581/581
(100 %)
0 diff
(100 %id)
AI752319 Bone, Hip .a 1608 to 2131 1 to 524       524/524
(100 %)
6 diff
(98.9 %id)
BG290014 bladder, transitional cell papilloma, cell line .a 1611 to 2242 1 to 639       636/644
(98 %)
15 diff
(97.7 %id)
BX424019 neuroblastoma .a 1643 to 2561 919 to 1       919/919
(100 %)
10 diff
(99.0 %id)
EL954633 eyeball .a 1645 to 2208 1 to 565       565/565
(100 %)
5 diff
(99.2 %id)
CN259331 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 1651 to 2342 9 to 700       692/700
(98 %)
6 diff
(99.2 %id)
AL518067 brain, neuroblastoma, neuroblastoma cells .a 1657 to 2517 904 to 44       861/906
(95 %)
18 diff
(98.1 %id)
AA329088   .a 1665 to 1966 1 to 303       303/303
(100 %)
1 diff
(99.7 %id)
BM930606 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 1673 to 2159 1 to 487   fully sequenced, Possibly primed on the genome, locally A rich (37/37 A in genome downstream of last aligned base) 487/487
(100 %)
0 diff
(100 %id)
BM833408 stomach .a 1685 to 2095 1 to 411       411/411
(100 %)
0 diff
(100 %id)
AW796258 uterus .a 1708 to 1963 22 to 276       255/302
(84 %)
8 diff
(97.4 %id)
R77568 placenta .a 1708 to 2073 1 to 368       368/439
(83 %)
5 diff
(98.9 %id)
AW796219 uterus .a 1711 to 1966 264 to 9       256/269
(95 %)
2 diff
(99.3 %id)
AA300827 testis .a 1730 to 2031 1 to 302       302/302
(100 %)
1 diff
(99.7 %id)
BU069713 insulinoma, Pancreas .a 1741 to 2341 1 to 601       601/601
(100 %)
4 diff
(99.4 %id)
BP196809 adrenal gland .a 1753 to 2331 1 to 579       579/579
(100 %)
0 diff
(100 %id)
BE618778 eye, retinoblastoma .a 1760 to 2571 813 to 3       811/908
(89 %)
13 diff
(98.6 %id)
H83314 eye, retina .a 1795 to 2100 1 to 308       308/332
(92 %)
4 diff
(98.8 %id)
AA186486   .a 1797 to 2336 1 to 554       554/565
(98 %)
17 diff
(97.0 %id)
BQ355631 head_neck .a 1799 to 1946 33 to 181       150/181
(82 %)
6 diff
(96.7 %id)
BP432591   .a 1804 to 2188 1 to 385       385/385
(100 %)
6 diff
(98.5 %id)
BQ014766 Chondrosarcoma, Left Pubic Bone .a 1805 to 2538 747 to 15   AAA Possibly primed on the genome, locally A rich (37/37 A in genome downstream of last aligned base) 733/733
(100 %)
1 diff
(99.9 %id)
BU622676 cell lines, Chondrosarcoma .a 1807 to 2588 790 to 19   AAA Possibly primed on the genome, locally A rich (37/37 A in genome downstream of last aligned base) 772/772
(100 %)
12 diff
(98.5 %id)
AA360504   .a 1813 to 2139 1 to 328       328/328
(100 %)
1 diff
(99.7 %id)
BI198423 brain, neuroblastoma .a 1813 to 2591 1 to 782       782/824
(94 %)
31 diff
(96.3 %id)
D78824 placenta .a 1829 to 2090 1 to 262       262/262
(100 %)
3 diff
(98.9 %id)
D78858 placenta .a 1829 to 2151 1 to 323       323/323
(100 %)
4 diff
(98.8 %id)
BU633763 cell lines, Chondrosarcoma .a 1831 to 2588 774 to 19   AAA Possibly primed on the genome, locally A rich (37/37 A in genome downstream of last aligned base) 756/756
(100 %)
4 diff
(99.5 %id)
BY995696   .a 1836 to 2560 49 to 771       723/771
(93 %)
6 diff
(99.3 %id)
CB159787 Liver .a 1837 to 2310 1 to 474       474/474
(100 %)
0 diff
(100 %id)
BQ446920 Knee, Osteoarthritic Cartilage .a 1841 to 2590 765 to 17   AAA Possibly primed on the genome, locally A rich (37/37 A in genome downstream of last aligned base) 749/750
(99 %)
2 diff
(99.8 %id)
TI_154117675   .a 1843 to 2588 850 to 108   AAA Possibly primed on the genome, locally A rich (37/37 A in genome downstream of last aligned base) 743/906
(82 %)
7 diff
(99.3 %id)
D81907 brain .a 1848 to 2355 1 to 503       503/503
(100 %)
9 diff
(98.3 %id)
CA424638 cell lines, Chondrosarcoma .a 1853 to 2590 750 to 17   AAA Possibly primed on the genome, locally A rich (37/37 A in genome downstream of last aligned base) 734/734
(100 %)
5 diff
(99.4 %id)
BX330305 Placenta Cot 25-normalized .a 1859 to 2576 725 to 4       722/933
(77 %)
15 diff
(98.4 %id)
CA434898 lung, Metastatic Chondrosarcoma .a 1859 to 2590 747 to 17   AAA Possibly primed on the genome, locally A rich (37/37 A in genome downstream of last aligned base) 731/731
(100 %)
7 diff
(99.1 %id)
BG528848 adenocarcinoma, Prostate .a 1863 to 2559 1 to 692       692/693
(99 %)
5 diff
(99.3 %id)
EH340085   .a 1865 to 1947 1 to 83       83/83
(100 %)
0 diff
(100 %id)
N98699 multiple sclerosis lesions .a 1869 to 2219 1 to 361   fully sequenced,   361/361
(100 %)
4 diff
(98.9 %id)
BF089446 head_neck .a 1875 to 2084 1 to 210       210/215
(97 %)
7 diff
(96.8 %id)
BF104164 embryonal carcinoma, testis .a 1876 to 2431 1 to 556   AAA   556/782
(71 %)
29 diff
(96.3 %id)
BF089445 head_neck .a 1883 to 2084 13 to 216       204/221
(92 %)
11 diff
(95.1 %id)
BU621966 Cell Line, Chondrosarcoma .a 1891 to 2590 714 to 17   AAA Possibly primed on the genome, locally A rich (37/37 A in genome downstream of last aligned base) 698/700
(99 %)
4 diff
(99.5 %id)
DA375066 thalamus .a 1894 to 2468 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
TI_154092256   .a 1901 to 2596 787 to 93   AAA Possibly primed on the genome, locally A rich (37/37 A in genome downstream of last aligned base) 695/905
(76 %)
3 diff
(99.7 %id)
CA434514 lung, Metastatic Chondrosarcoma .a 1901 to 2596 713 to 19   AAA Possibly primed on the genome, locally A rich (37/37 A in genome downstream of last aligned base) 695/706
(98 %)
3 diff
(99.6 %id)
DA169816 amygdala .a 1906 to 2478 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
AA724174 parathyroid gland, parathyroid tumor .a 1907 to 2298 44 to 437     Submitted on the opposite strand 394/438
(89 %)
11 diff
(97.5 %id)
N90043 parathyroid gland, parathyroid tumor .a 1907 to 2140 39 to 273     Submitted on the opposite strand 235/276
(85 %)
7 diff
(97.5 %id)
BE644805 pooled .a 1907 to 2462 44 to 601     Submitted on the opposite strand 558/601
(92 %)
7 diff
(98.9 %id)
CN259327 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 1918 to 2585 8 to 676       669/676
(98 %)
10 diff
(98.6 %id)
CA449737 Chondrosarcoma, Left Pelvis .a 1922 to 2588 685 to 19   AAA Possibly primed on the genome, locally A rich (37/37 A in genome downstream of last aligned base) 667/667
(100 %)
0 diff
(100 %id)
CA423943 cell lines, Chondrosarcoma .a 1922 to 2588 685 to 19   AAA Possibly primed on the genome, locally A rich (37/37 A in genome downstream of last aligned base) 667/667
(100 %)
1 diff
(99.9 %id)
CN259330 embryonic stem cells, DMSO-treated H9 cellline .a 1924 to 2221 1 to 298       298/298
(100 %)
0 diff
(100 %id)
CA426398 cell lines, Chondrosarcoma .a 1930 to 2596 685 to 19   AAA Possibly primed on the genome, locally A rich (37/37 A in genome downstream of last aligned base) 667/667
(100 %)
0 diff
(100 %id)
BF087512 head_neck .a 1931 to 2457 32 to 557       525/562
(93 %)
8 diff
(98.6 %id)
BF056891 pooled germ cell tumors .a 1934 to 2592 659 to 1       659/673
(97 %)
5 diff
(99.3 %id)
CF242920 Brain glioblastoma .a 1976 to 2815 1 to 845       845/845
(100 %)
8 diff
(99.1 %id)
BF352331 head_neck .a 1980 to 2298 12 to 331       320/341
(93 %)
8 diff
(97.7 %id)
AI633878 pooled germ cell tumors .a 1980 to 2592 613 to 1       613/613
(100 %)
7 diff
(98.9 %id)
AW088411 ovary, tumor, 5 pooled (see description) .a 2004 to 2596 593 to 1       593/593
(100 %)
5 diff
(99.2 %id)
AW515316 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 2004 to 2596 605 to 13   AAA Possibly primed on the genome, locally A rich (37/37 A in genome downstream of last aligned base) 593/593
(100 %)
1 diff
(99.9 %id)
BE042542 colon, moderately-differentiated adenocarcinoma .a 2009 to 2590 603 to 22   AAA Possibly primed on the genome, locally A rich (37/37 A in genome downstream of last aligned base) 582/584
(99 %)
7 diff
(98.9 %id)
BU069493 insulinoma, Pancreas .a 2009 to 2596 602 to 15   AAA Possibly primed on the genome, locally A rich (37/37 A in genome downstream of last aligned base) 588/588
(100 %)
0 diff
(100 %id)
CD512531 Pooled-Skin .a 2010 to 2586 1 to 579       579/792
(73 %)
8 diff
(99.0 %id)
CA424829 cell lines, Chondrosarcoma .a 2030 to 2588 577 to 19   AAA Possibly primed on the genome, locally A rich (37/37 A in genome downstream of last aligned base) 559/559
(100 %)
1 diff
(99.9 %id)
CA430700 cell lines, Chondrosarcoma .a 2032 to 2686 673 to 19   AAA Possibly primed on the genome, locally A rich (37/37 A in genome downstream of last aligned base) 655/655
(100 %)
0 diff
(100 %id)
BE218306 carcinoid, lung .a 2040 to 2595 556 to 1       556/556
(100 %)
1 diff
(99.9 %id)
AI818209 adenocarcinoma, Pancreas .a 2046 to 2588 560 to 19   AAA Possibly primed on the genome, locally A rich (37/37 A in genome downstream of last aligned base) 542/542
(100 %)
9 diff
(98.4 %id)
AW083012 colon, moderately differentiated adenocarcinoma .a 2046 to 2596 547 to 1       547/547
(100 %)
6 diff
(99.0 %id)
AA043666 uterus .a 2067 to 2276 1 to 210       210/210
(100 %)
1 diff
(99.6 %id)
DW409800 Liver .a 2069 to 2390 16 to 337       322/337
(95 %)
9 diff
(97.4 %id)
AW207435   .a 2071 to 2596 543 to 18   AAA Possibly primed on the genome, locally A rich (37/37 A in genome downstream of last aligned base) 526/526
(100 %)
2 diff
(99.7 %id)
CN259324 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 2088 to 2673 7 to 592       586/592
(98 %)
0 diff
(100 %id)
BI223165 cervical carcinoma cell line, cervix .a 2098 to 2596 1 to 500   AAA Possibly primed on the genome, locally A rich (37/37 A in genome downstream of last aligned base) 500/500
(100 %)
1 diff
(99.8 %id)
AA043792 uterus .a 2110 to 2588 500 to 17   AAA Possibly primed on the genome, locally A rich (37/37 A in genome downstream of last aligned base) 484/485
(99 %)
11 diff
(97.8 %id)
CN259325 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 2112 to 2593 9 to 490       482/490
(98 %)
6 diff
(98.8 %id)
DA485075 brain .a 2116 to 2696 2 to 583   capped   582/582
(100 %)
1 diff
(99.9 %id)
AW410334 muscle, rhabdomyosarcoma .a 2116 to 2590 493 to 19   AAA Possibly primed on the genome, locally A rich (37/37 A in genome downstream of last aligned base) 475/475
(100 %)
3 diff
(99.4 %id)
AI420205 Prostate .a 2122 to 2596 482 to 9       474/482
(98 %)
1 diff
(99.8 %id)
AA431514   .a 2126 to 2553 1 to 428       428/428
(100 %)
1 diff
(99.8 %id)
BP396636 pancreatic islet .a 2127 to 2471 1 to 348     Submitted on the opposite strand 348/348
(100 %)
7 diff
(98.0 %id)
BU743258 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 2129 to 2588 478 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (37/37 A in genome downstream of last aligned base) 460/460
(100 %)
0 diff
(100 %id)
BE465917 Kidney .a 2130 to 2596 467 to 1       467/467
(100 %)
0 diff
(100 %id)
AI752320 Bone, Hip .a 2132 to 2557 433 to 8       426/433
(98 %)
0 diff
(100 %id)
AI283114 placenta .a 2141 to 2592 456 to 1       456/456
(100 %)
3 diff
(99.4 %id)
AI743602 pooled .a 2143 to 2596 463 to 10       454/463
(98 %)
0 diff
(100 %id)
BU166272 melanotic melanoma, skin .a 2146 to 2588 5 to 447   AAA Possibly primed on the genome, locally A rich (37/37 A in genome downstream of last aligned base) 443/447
(99 %)
6 diff
(98.7 %id)
BP397589 pancreatic islet .a 2156 to 2589 1 to 435     Submitted on the opposite strand 435/437
(99 %)
2 diff
(99.6 %id)
AI417561 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 2156 to 2596 442 to 2       441/442
(99 %)
0 diff
(100 %id)
C00128   .a 2160 to 2506 1 to 347       347/349
(99 %)
1 diff
(99.8 %id)
W00707 lung .a 2160 to 2590 1 to 429   AAA Possibly primed on the genome, locally A rich (37/37 A in genome downstream of last aligned base) 429/429
(100 %)
2 diff
(99.6 %id)
BF998349 placenta_normal .a 2161 to 2524 9 to 371       363/376
(96 %)
14 diff
(96.3 %id)
N66098 multiple sclerosis lesions .a 2161 to 2596 436 to 1   fully sequenced,   436/436
(100 %)
0 diff
(100 %id)
FN072012 breast carcinoma .a 2162 to 2249 1 to 87       87/87
(100 %)
3 diff
(96.6 %id)
AA573278 colon .a 2162 to 2592 434 to 4       431/434
(99 %)
0 diff
(100 %id)
AI819645 lymph node, lymphoma, follicular mixed small and largecell .a 2172 to 2596 430 to 6       425/430
(98 %)
0 diff
(100 %id)
R61473 whole brain .a 2383 to 2588 222 to 17   AAA Possibly primed on the genome, locally A rich (37/37 A in genome downstream of last aligned base) 206/206
(100 %)
0 diff
(100 %id)
AA187281   .a 3582 to 3979 401 to 1       401/401
(100 %)
4 diff
(99.1 %id)
BG036911 brain, hippocampus .b 1 to 637 1 to 631   tiling clone,   631/926
(68 %)
18 diff
(98.1 %id)
BC004183 Muscle, rhabdomyosarcoma .b 17 to 2479 1 to 2463 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (37/37 A in genome downstream of last aligned base) 2463/2463
(100 %)
0 diff
(100 %id)
BC007219 Muscle, rhabdomyosarcoma .b 17 to 2479 1 to 2463   available from MGC, AAA Possibly primed on the genome, locally A rich (37/37 A in genome downstream of last aligned base) 2463/2463
(100 %)
0 diff
(100 %id)
AU131122   .b 113 to 815 2 to 705   capped   704/715
(98 %)
7 diff
(99.1 %id)
CR457299   .b 282 to 2204 1 to 1923 H164Y E348V     1923/1923
(100 %)
2 diff
(99.9 %id)
TI_1948154480   .b 282 to 1229 125 to 1066   fully sequenced,   942/1066
(88 %)
26 diff
(97.6 %id)
TI_1948154796   .b 282 to 1253 125 to 1094   fully sequenced,   970/1094
(88 %)
42 diff
(96.2 %id)
TI_1948154956   .b 282 to 1233 124 to 1066   fully sequenced,   943/1066
(88 %)
28 diff
(97.4 %id)
BU517080 leiomyosarcoma, uterus .b 497 to 1334 1 to 844       842/870
(96 %)
12 diff
(98.7 %id)
BU156525 eye, retinoblastoma .b 582 to 1408 1 to 834       834/859
(97 %)
7 diff
(99.2 %id)
BY994439   .b 609 to 1321 2 to 712       711/712
(99 %)
10 diff
(98.6 %id)
BI088992 cervix .b 698 to 1404 1 to 709       711/855
(83 %)
20 diff
(97.7 %id)
BP379302 uterus .b 718 to 1298 1 to 581       581/581
(100 %)
0 diff
(100 %id)
BP340322 Spleen .b 719 to 1299 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
TI_1948154797   .b 1152 to 2203 1172 to 126   fully sequenced,   1047/1172
(89 %)
46 diff
(96.1 %id)
TI_1948154481   .b 1199 to 2203 1131 to 130   fully sequenced,   1002/1131
(88 %)
23 diff
(98.0 %id)
TI_1948154957   .b 1203 to 2203 1131 to 130   fully sequenced,   1002/1131
(88 %)
27 diff
(97.7 %id)
AI434568 lymph node, lymphoma, follicular mixed small and largecell .b 2073 to 2477 405 to 1       405/405
(100 %)
0 diff
(100 %id)
AA973972 carcinoid, lung .b 2079 to 2484 406 to 1       406/406
(100 %)
0 diff
(100 %id)
AI631297 adenocarcinoma, Pancreas .b 2089 to 2479 408 to 18   AAA Possibly primed on the genome, locally A rich (37/37 A in genome downstream of last aligned base) 391/391
(100 %)
0 diff
(100 %id)
AI638738 pooled germ cell tumors .b 2115 to 2481 367 to 1       367/367
(100 %)
1 diff
(99.8 %id)
AI440413 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .b 2117 to 2481 366 to 2       365/366
(99 %)
0 diff
(100 %id)
TI_57242040   .b 2122 to 2813 28 to 720       693/720
(96 %)
6 diff
(99.2 %id)
BI914941 brain .b 2125 to 2813 1 to 690       690/690
(100 %)
7 diff
(99.0 %id)
AI702887 Kidney .b 2128 to 2480 382 to 29       354/382
(92 %)
0 diff
(100 %id)
AA653570   .b 2136 to 2481 347 to 2       346/347
(99 %)
0 diff
(100 %id)
CX866994 embryonic stem .b 2148 to 2935 1 to 787       787/787
(100 %)
1 diff
(99.9 %id)
AA096434   .b 2155 to 2308 1 to 153       153/153
(100 %)
2 diff
(98.7 %id)
AI753861 bone marrow stroma .b 2157 to 2485 347 to 19   AAA Possibly primed on the genome, locally A rich (37/37 A in genome downstream of last aligned base) 329/329
(100 %)
0 diff
(100 %id)
AA809488 germinal center B cell .b 2168 to 2481 319 to 6       314/319
(98 %)
0 diff
(100 %id)
AI962149 normal epithelium, ovary .b 2168 to 2477 322 to 13   AAA Possibly primed on the genome, locally A rich (37/37 A in genome downstream of last aligned base) 310/310
(100 %)
1 diff
(99.7 %id)
AI440138 lymph node, lymphoma, follicular mixed small and largecell .b 2175 to 2485 311 to 1       311/311
(100 %)
0 diff
(100 %id)
AL135399 melanoma (MeWo cell line) .b 2184 to 2943 1 to 760       760/760
(100 %)
0 diff
(100 %id)
BX389372 Neuroblastoma Cot 10-normalized .b 2191 to 3037 1 to 850       850/855
(99 %)
36 diff
(95.8 %id)
BG027920 Bone, osteosarcoma, cell line .b 2191 to 2951 1 to 763       763/882
(86 %)
38 diff
(95.7 %id)
D62361   .b 2196 to 2485 1 to 290       290/290
(100 %)
0 diff
(100 %id)
AW089455 brain, tumor, 5 pooled (see description) .b 2199 to 2481 285 to 3       283/285
(99 %)
0 diff
(100 %id)
AI925346 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .b 2213 to 2485 275 to 3       273/275
(99 %)
0 diff
(100 %id)
CA428911 Cell Line, Chondrosarcoma .b 2224 to 2481 274 to 17       258/274
(94 %)
0 diff
(100 %id)
BX371333 Neuroblastoma Cot 10-normalized .b 2230 to 3092 874 to 16       859/922
(93 %)
0 diff
(100 %id)
AA174177   .b 2248 to 2485 241 to 6       236/241
(97 %)
0 diff
(100 %id)
BQ023845 placenta .b 2261 to 2479 235 to 17   AAA Possibly primed on the genome, locally A rich (37/37 A in genome downstream of last aligned base) 219/219
(100 %)
0 diff
(100 %id)
BJ994154 hepatoblastoma .b 2267 to 2752 1 to 486       486/486
(100 %)
1 diff
(99.8 %id)
AA350598 brain .b 2268 to 2485 218 to 1       218/218
(100 %)
0 diff
(100 %id)
AW514435 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .b 2288 to 2485 204 to 7       198/204
(97 %)
0 diff
(100 %id)
BU588031 mixed (pool of 40 RNAs) .b 2288 to 2442 1 to 155   AAA Possibly primed on the genome, locally A rich (37/37 A in genome downstream of last aligned base) 155/155
(100 %)
2 diff
(98.8 %id)
CN259322 embryonic stem cells, cell lines H1, H7, andH9 .b 2291 to 3002 1 to 711       711/712
(99 %)
3 diff
(99.6 %id)
BM768336 stomach .b 2300 to 2479 1 to 180   AAA Possibly primed on the genome, locally A rich (37/37 A in genome downstream of last aligned base) 180/180
(100 %)
0 diff
(100 %id)
FN137601 breast carcinoma .b 2314 to 2405 1 to 88       88/88
(100 %)
4 diff
(95.5 %id)
FN073526 breast carcinoma .b 2317 to 2397 80 to 1     Submitted on the opposite strand 80/81
(98 %)
1 diff
(98.8 %id)
DR158021 human embryonic stem cells differentiated toan early endodermal cell type .b 2332 to 3118 1 to 787   tiling clone,   787/787
(100 %)
0 diff
(100 %id)
AA427677 ovarian tumor, ovary .b 2338 to 2782 1 to 445       445/450
(98 %)
4 diff
(99.2 %id)
BX090700 ovarian tumor, ovary .b 2339 to 3064 1 to 731       731/731
(100 %)
4 diff
(99.5 %id)
AI624981 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .b 2344 to 2485 143 to 2       142/143
(99 %)
0 diff
(100 %id)
EC456516 Prostate .b 2357 to 2476 121 to 3       119/121
(98 %)
0 diff
(100 %id)
CN259315 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 2370 to 3002 9 to 641       633/642
(98 %)
1 diff
(99.9 %id)
W19853 parathyroid gland, parathyroid tumor .b 2370 to 2802 434 to 1     Submitted on the opposite strand 434/434
(100 %)
1 diff
(99.8 %id)
BF031562 hypernephroma, Kidney .b 2454 to 3138 1 to 678       678/807
(84 %)
32 diff
(96.1 %id)
FN073242 breast carcinoma .b 2468 to 2527 1 to 60       60/60
(100 %)
0 diff
(100 %id)
BF432696 brain, glioblastoma (pooled) .b 2545 to 2923 384 to 6       379/384
(98 %)
0 diff
(100 %id)
N21466 melanocyte .b 2583 to 3106 527 to 1       527/527
(100 %)
5 diff
(99.1 %id)
BP215822 corpus callosum .b 2586 to 3165 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
BP314500 mammary gland .b 2608 to 3189 1 to 582       582/582
(100 %)
0 diff
(100 %id)
AA349432 brain .b 2634 to 3041 1 to 408       408/408
(100 %)
0 diff
(100 %id)
AW957184   .b 2634 to 3428 11 to 805       795/805
(98 %)
8 diff
(99.1 %id)
CF141876 CNCAP(3)T-225 cell line, Prostate .b 2660 to 3182 8 to 529       522/529
(98 %)
6 diff
(98.9 %id)
TI_154172683   .b 2660 to 3240 87 to 670       584/1348
(43 %)
10 diff
(99.3 %id)
BG623647 placenta .b 2673 to 3390 1 to 717       717/718
(99 %)
6 diff
(99.2 %id)
AI278309 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 2691 to 3106 416 to 1       416/416
(100 %)
0 diff
(100 %id)
AA328062   .b 2813 to 3102 1 to 291       291/293
(99 %)
5 diff
(98.3 %id)
N78427 multiple sclerosis lesions .b 2825 to 3045 1 to 221       221/221
(100 %)
0 diff
(100 %id)
CN259329 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 2879 to 3285 1 to 407       407/407
(100 %)
0 diff
(100 %id)
CN259317 embryonic stem cells, cell lines H1, H7, andH9 .b 2884 to 3376 1 to 493       493/493
(100 %)
0 diff
(100 %id)
AL520230 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .b 2884 to 3868 981 to 1   tiling clone,   981/989
(99 %)
18 diff
(98.2 %id)
AA054496 uterus .b 2942 to 3421 1 to 484   fully sequenced,   484/484
(100 %)
6 diff
(98.8 %id)
CA311452 Human Lung Epithelial cells, lung .b 2949 to 3618 688 to 19   AAA Possibly primed on the genome, locally A rich (37/37 A in genome downstream of last aligned base) 670/691
(96 %)
0 diff
(100 %id)
AA310489   .b 2972 to 3449 1 to 478       478/478
(100 %)
0 diff
(100 %id)
T39783 fetal spleen, Spleen .b 2989 to 3279 1 to 291       291/291
(100 %)
7 diff
(97.6 %id)
T39804 fetal spleen, Spleen .b 2989 to 3283 1 to 295       295/295
(100 %)
2 diff
(99.4 %id)
BG003474 placenta_normal .b 2997 to 3444 14 to 460       447/460
(97 %)
6 diff
(98.7 %id)
DN918649   .b 3021 to 3566 1 to 546       546/546
(100 %)
1 diff
(99.9 %id)
BE883723 leiomyosarcoma, uterus .b 3025 to 3712 1 to 691       691/967
(71 %)
22 diff
(97.8 %id)
TI_149309311   .b 3035 to 3876 921 to 88   AAA Possibly primed on the genome, locally A rich (37/37 A in genome downstream of last aligned base) 834/974
(85 %)
23 diff
(97.7 %id)
BP379783 uterus .b 3035 to 3585 1 to 552       552/552
(100 %)
3 diff
(99.5 %id)
BU618658 Cell Line, Chondrosarcoma .b 3040 to 3705 684 to 19   AAA Possibly primed on the genome, locally A rich (37/37 A in genome downstream of last aligned base) 666/666
(100 %)
0 diff
(100 %id)
TI_154047402   .b 3086 to 3881 864 to 75   AAA Possibly primed on the genome, locally A rich (37/37 A in genome downstream of last aligned base) 790/929
(85 %)
29 diff
(96.9 %id)
CA313068 Human Lung Epithelial cells, lung .b 3095 to 3881 804 to 19   AAA Possibly primed on the genome, locally A rich (37/37 A in genome downstream of last aligned base) 786/786
(100 %)
6 diff
(99.3 %id)
BG032703 breast, mammary adenocarcinoma, cell line .b 3118 to 3705 1 to 588   AAA Possibly primed on the genome, locally A rich (37/37 A in genome downstream of last aligned base) 588/588
(100 %)
1 diff
(99.9 %id)
FN070212 breast carcinoma .b 3122 to 3205 1 to 85       85/86
(98 %)
2 diff
(97.7 %id)
BF966712 brain, hippocampus .b 3137 to 3828 700 to 4       697/969
(71 %)
0 diff
(100 %id)
BU618799 Cell Line, Chondrosarcoma .b 3163 to 3881 737 to 19   AAA Possibly primed on the genome, locally A rich (37/37 A in genome downstream of last aligned base) 719/719
(100 %)
2 diff
(99.8 %id)
BM695067 eye, human retina .b 3193 to 3476 1 to 285   fully sequenced, Possibly primed on the genome, locally A rich (37/37 A in genome downstream of last aligned base) 285/285
(100 %)
1 diff
(99.7 %id)
TI_227713074   .b 3198 to 4222 1103 to 88   tiling clone, AAA Possibly primed on the genome, locally A rich (37/37 A in genome downstream of last aligned base) 1016/1035
(98 %)
25 diff
(97.6 %id)
AI366801   .b 3209 to 3625 1 to 417     Submitted on the opposite strand 417/417
(100 %)
4 diff
(99.1 %id)
BU687719 lung .b 3229 to 3876 665 to 19   AAA Possibly primed on the genome, locally A rich (37/37 A in genome downstream of last aligned base) 647/647
(100 %)
3 diff
(99.6 %id)
BE763696 nervous_tumor .b 3279 to 3741 471 to 9       463/480
(96 %)
0 diff
(100 %id)
AA427532 ovarian tumor, ovary .b 3289 to 3717 429 to 1       429/429
(100 %)
1 diff
(99.8 %id)
CB250509 Human Lung Epithelial cells, lung .b 3291 to 3618 346 to 19   AAA Possibly primed on the genome, locally A rich (37/37 A in genome downstream of last aligned base) 328/328
(100 %)
6 diff
(98.2 %id)
AA292619 germinal center B cell .b 3310 to 3460 1 to 151       151/151
(100 %)
4 diff
(97.4 %id)
DN918650   .b 3331 to 3887 552 to 1       552/556
(99 %)
5 diff
(99.2 %id)
AA126569 uterus .b 3333 to 3477 1 to 146   fully sequenced,   146/146
(100 %)
1 diff
(99.4 %id)
AA345941 gall bladder .b 3334 to 3728 1 to 395       395/395
(100 %)
1 diff
(99.8 %id)
AA349431 brain .b 3339 to 3747 409 to 1       409/409
(100 %)
0 diff
(100 %id)
BU954002 mixed (pool of 40 RNAs) .b 3357 to 3877 1 to 523       523/981
(53 %)
7 diff
(99.3 %id)
BG054496 Kidney .b 3362 to 3887 540 to 15   AAA Possibly primed on the genome, locally A rich (37/37 A in genome downstream of last aligned base) 526/526
(100 %)
1 diff
(99.9 %id)
AW771521 Kidney .b 3373 to 3881 509 to 1       509/509
(100 %)
0 diff
(100 %id)
AW514659 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .b 3384 to 3876 493 to 1       493/493
(100 %)
1 diff
(99.8 %id)
AA058340 uterus .b 3391 to 3887 505 to 1   fully sequenced,   505/505
(100 %)
19 diff
(96.3 %id)
AI332895 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 3400 to 3744 355 to 11   AAA Possibly primed on the genome, locally A rich (37/37 A in genome downstream of last aligned base) 345/345
(100 %)
0 diff
(100 %id)
DB547025 hippocampus .b 3414 to 3876 1 to 463     Submitted on the opposite strand 463/463
(100 %)
1 diff
(99.8 %id)
AA938728 germinal center B cell .b 3417 to 3876 476 to 17   AAA Possibly primed on the genome, locally A rich (37/37 A in genome downstream of last aligned base) 460/460
(100 %)
2 diff
(99.6 %id)
AW182807 pooled .b 3418 to 3887 480 to 11   AAA Possibly primed on the genome, locally A rich (37/37 A in genome downstream of last aligned base) 470/470
(100 %)
0 diff
(100 %id)
AW771502 Kidney .b 3426 to 3881 456 to 1       456/456
(100 %)
0 diff
(100 %id)
AI493810 Kidney .b 3431 to 3888 458 to 1       458/458
(100 %)
2 diff
(99.6 %id)
AI090291 uterus .b 3436 to 3887 452 to 1       452/452
(100 %)
0 diff
(100 %id)
AW675411 cervix .b 3437 to 3888 456 to 5       452/456
(99 %)
0 diff
(100 %id)
BF516057   .b 3444 to 3942 1 to 499     Submitted on the opposite strand 499/499
(100 %)
6 diff
(98.8 %id)
C02522   .b 3445 to 3796 1 to 352       352/352
(100 %)
1 diff
(99.8 %id)
BM666850 eye, human retina .b 3446 to 3887 459 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (37/37 A in genome downstream of last aligned base) 441/441
(100 %)
9 diff
(98.0 %id)
AA126445 uterus .b 3447 to 3882 431 to 1   fully sequenced,   431/431
(100 %)
2 diff
(99.6 %id)
D61745   .b 3455 to 3688 1 to 234       234/234
(100 %)
0 diff
(100 %id)
D79887 aorta .b 3457 to 3851 1 to 387       387/391
(98 %)
10 diff
(97.5 %id)
DB561989 hypothalamus .b 3459 to 3881 1 to 423     Submitted on the opposite strand 423/423
(100 %)
1 diff
(99.8 %id)
N62707 multiple sclerosis lesions .b 3462 to 3888 430 to 1       430/430
(100 %)
3 diff
(99.4 %id)
AW512566 lymph node, lymphoma, follicular mixed small and largecell .b 3475 to 3886 412 to 1       412/412
(100 %)
2 diff
(99.6 %id)
DB517191 testis .b 3487 to 3886 1 to 400     Submitted on the opposite strand 400/401
(99 %)
7 diff
(98.3 %id)
AW189042 serous papillary carcinoma, high grade, 2pooled tumors, uterus .b 3491 to 3881 391 to 1       391/391
(100 %)
3 diff
(99.3 %id)
CD367418 Alveolar Macrophage, lung .b 3494 to 4222 743 to 15   AAA Possibly primed on the genome, locally A rich (37/37 A in genome downstream of last aligned base) 729/730
(99 %)
0 diff
(100 %id)
AA588743 colon, colon tumor .b 3503 to 3888 392 to 7       386/392
(98 %)
0 diff
(100 %id)
AW089555 ovary, tumor, 5 pooled (see description) .b 3503 to 3887 423 to 39   AAA Possibly primed on the genome, locally A rich (37/37 A in genome downstream of last aligned base) 385/385
(100 %)
4 diff
(99.0 %id)
AI678159 Prostate .b 3511 to 3877 367 to 1       367/367
(100 %)
0 diff
(100 %id)
AA456027 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 3524 to 3835 312 to 1       312/312
(100 %)
2 diff
(99.4 %id)
AA829470 germinal center B cell .b 3529 to 3876 364 to 17   AAA Possibly primed on the genome, locally A rich (37/37 A in genome downstream of last aligned base) 348/348
(100 %)
0 diff
(100 %id)
AA970774 pooled .b 3548 to 3882 335 to 1       335/335
(100 %)
1 diff
(99.8 %id)
T40865 fetal spleen, Spleen .b 3549 to 3888 343 to 4       340/343
(99 %)
0 diff
(100 %id)
AW149169 Kidney, renal cell tumor .b 3606 to 3887 292 to 11   AAA Possibly primed on the genome, locally A rich (37/37 A in genome downstream of last aligned base) 282/282
(100 %)
1 diff
(99.7 %id)
AI220712 placenta .b 3617 to 3888 273 to 2       272/273
(99 %)
0 diff
(100 %id)
T40872 fetal spleen, Spleen .b 3627 to 3888 265 to 4       262/265
(98 %)
0 diff
(100 %id)
AI932606 adenocarcinoma, Pancreas .b 3637 to 3887 270 to 21   AAA Possibly primed on the genome, locally A rich (37/37 A in genome downstream of last aligned base) 250/250
(100 %)
2 diff
(99.2 %id)
AI587187 adenocarcinoma, Pancreas .b 3654 to 3887 234 to 1       234/234
(100 %)
1 diff
(99.6 %id)
AU152940   .b 3667 to 4218 549 to 1       549/549
(100 %)
14 diff
(97.5 %id)
EC492369 Prostate .b 3695 to 3808 1 to 111       111/114
(97 %)
4 diff
(96.5 %id)
AA767314 germinal center B cell .b 3760 to 4222 474 to 12   AAA Possibly primed on the genome, locally A rich (37/37 A in genome downstream of last aligned base) 463/463
(100 %)
1 diff
(99.8 %id)
AA766576 germinal center B cell .b 3805 to 4224 436 to 18       419/436
(96 %)
0 diff
(100 %id)
AA292620 germinal center B cell .b 3807 to 4222 416 to 1       416/416
(100 %)
1 diff
(99.8 %id)
BE349516 malignant melanoma, metastatic to lymphnode, skin .b 3824 to 4272 463 to 15   tiling clone, AAA Possibly primed on the genome, locally A rich (37/37 A in genome downstream of last aligned base) 449/449
(100 %)
1 diff
(99.8 %id)
AA766639 germinal center B cell .b 3873 to 4224 372 to 19   AAA Possibly primed on the genome, locally A rich (37/37 A in genome downstream of last aligned base) 354/354
(100 %)
7 diff
(98.1 %id)
AI917203 pooled germ cell tumors .b 3890 to 4236 368 to 22   AAA Possibly primed on the genome, locally A rich (37/37 A in genome downstream of last aligned base) 347/347
(100 %)
0 diff
(100 %id)
AI668846 Prostate .b 3975 to 4236 262 to 1       262/262
(100 %)
0 diff
(100 %id)
BE673324 Prostate .b 3975 to 4236 262 to 1       262/262
(100 %)
0 diff
(100 %id)
FN150100 breast carcinoma .b 4056 to 4132 1 to 77       77/77
(100 %)
1 diff
(98.8 %id)
DA381502 thalamus .c 1 to 450 9 to 458   capped   457/457
(100 %)
0 diff
(100 %id)
AK094075 uterus .c 1 to 2297 3 to 2299 T435A tiling clone, available from FLJ,   2299/2299
(100 %)
3 diff
(99.9 %id)
DB260692 uterus .c 1 to 585 3 to 587   capped   586/586
(100 %)
0 diff
(100 %id)
DA122636 cerebellum .c 1 to 535 2 to 537   capped   536/536
(100 %)
1 diff
(99.9 %id)
DA378888 thalamus .c 1 to 549 2 to 550   capped   549/549
(100 %)
1 diff
(99.9 %id)
BG260989 bladder, transitional cell papilloma, cell line .c 543 to 1207 1 to 674       671/676
(99 %)
25 diff
(96.4 %id)
BM016428 breast, mammary adenocarcinoma, cell line .c 571 to 1343 1 to 777       777/881
(88 %)
7 diff
(99.3 %id)
TI_59393358   .c 571 to 1343 91 to 867       777/881
(88 %)
7 diff
(99.3 %id)
CN259326 embryonic stem cells, DMSO-treated H9 cellline .c 573 to 1262 1 to 690       690/690
(100 %)
0 diff
(100 %id)
CN259323 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 669 to 1343 1 to 675       675/682
(98 %)
2 diff
(99.8 %id)
CF141547 CNCAP(3)T-225 cell line, Prostate .c 759 to 1246 1 to 488       488/488
(100 %)
4 diff
(99.2 %id)
TI_154172301   .c 766 to 1418 91 to 743       653/1080
(60 %)
20 diff
(98.2 %id)
AA350599 brain .c 779 to 1199 1 to 422       422/422
(100 %)
1 diff
(99.8 %id)
BP300214   .c 781 to 1364 1 to 583       583/583
(100 %)
1 diff
(99.9 %id)
AA280575 germinal center B cell .c 801 to 1167 11 to 377       367/377
(97 %)
7 diff
(98.2 %id)
BG121474 adenocarcinoma, cell line, Liver .c 850 to 1616 1 to 760       760/904
(84 %)
17 diff
(98.2 %id)
BP315391 mammary gland .c 870 to 1451 1 to 582       582/582
(100 %)
0 diff
(100 %id)
DB068127 testis .c 875 to 1412 2 to 539   capped   538/538
(100 %)
0 diff
(100 %id)
BI261167 cervical carcinoma cell line, cervix .c 927 to 1541 71 to 685       615/685
(89 %)
6 diff
(99.2 %id)
BM739991 Ascites, stomach .c 958 to 1461 1 to 503       503/503
(100 %)
1 diff
(99.9 %id)
BM739371 Ascites, stomach .c 958 to 1583 1 to 626       626/626
(100 %)
0 diff
(100 %id)
BM738967 Ascites, stomach .c 958 to 1554 1 to 596       596/596
(100 %)
4 diff
(99.4 %id)
BM739416 Ascites, stomach .c 996 to 1392 1 to 398       398/398
(100 %)
7 diff
(98.3 %id)
CX785593 human embryonic stem cells .c 1045 to 1909 1 to 865   tiling clone,   865/865
(100 %)
6 diff
(99.4 %id)
DB351621 uterus .c 1806 to 2297 494 to 1       494/516
(95 %)
9 diff
(98.3 %id)
DA182280 amygdala .d 1 to 572 2 to 574   tiling clone, to resequence, capped   573/573
(100 %)
6 diff
(99.0 %id)
DB302954 amygdala .d 1232 to 1799 568 to 1   tiling clone, to resequence,   568/568
(100 %)
0 diff
(100 %id)
BE782129 eye, retinoblastoma .e 1 to 725 1 to 727 A201V D202M D203I L204F H205T ... tiling clone,   727/970
(74 %)
9 diff
(99.1 %id)
AK001928 placenta .f 1 to 1942 2 to 1943 exact tiling clone, available from FLJ,   1943/1943
(100 %)
1 diff
(100.0 %id)
AU136697 placenta .f 1 to 678 2 to 681   capped   680/682
(99 %)
4 diff
(99.5 %id)
AU156826 placenta .f 1449 to 1942 494 to 1       494/496
(99 %)
16 diff
(96.8 %id)
AL044986 testis .f 1940 to 2550 1 to 612   tiling clone,   612/622
(98 %)
3 diff
(99.6 %id)
DA361263 subthalamic nucleus .g 1 to 540 2 to 541   tiling clone, to resequence, capped   540/540
(100 %)
0 diff
(100 %id)
AL712250 human skeletal muscle .g 408 to 798 1 to 391   tiling clone,   391/391
(100 %)
0 diff
(100 %id)
AW798793 uterus .g 513 to 868 428 to 73   tiling clone,   356/428
(83 %)
0 diff
(100 %id)
AI669659 Prostate .g 939 to 1479 547 to 7   tiling clone,   541/547
(98 %)
0 diff
(100 %id)
AI927938 Kidney .g 955 to 1475 521 to 1       521/521
(100 %)
5 diff
(99.1 %id)
AA902264 carcinoid, lung .g 978 to 1482 507 to 1       507/531
(95 %)
8 diff
(98.5 %id)
BQ430395 embryonal carcinoma, cell line, testis .g 979 to 1789 8 to 825   tiling clone,   822/925
(88 %)
17 diff
(98.2 %id)
AW105148 pooled .g 984 to 1483 512 to 13   AAA Possibly primed on the genome, locally A rich (37/37 A in genome downstream of last aligned base) 500/503
(99 %)
2 diff
(99.7 %id)
BE465947 pooled germ cell tumors .g 989 to 1477 489 to 1       489/489
(100 %)
0 diff
(100 %id)
CK902378 insulinoma, Pancreas .g 990 to 1483 504 to 11   AAA Possibly primed on the genome, locally A rich (37/37 A in genome downstream of last aligned base) 494/494
(100 %)
5 diff
(99.0 %id)
DB310595 subthalamic nucleus .g 1275 to 1483 211 to 1   to resequence,   211/211
(100 %)
2 diff
(99.1 %id)
BF837084 head_neck .h 1 to 442 28 to 467 L3C I7T Q8T H9S L10V ... tiling clone, AAA Possibly primed on the genome, locally A rich (37/37 A in genome downstream of last aligned base) 440/467
(94 %)
11 diff
(97.7 %id)
BP398614 pancreatic islet .i-u 1 to 502 1 to 502   tiling clone, Submitted on the opposite strand 502/502
(100 %)
0 diff
(100 %id)
AA704575 pineal gland .i-u 39 to 502 464 to 1       464/464
(100 %)
2 diff
(99.6 %id)
AI749472 aorta .i-u 46 to 502 457 to 1       457/457
(100 %)
6 diff
(98.7 %id)
AW275782 normal squamous epithelium, tongue .i-u 108 to 502 422 to 28   AAA Possibly primed on the genome, locally A rich (37/37 A in genome downstream of last aligned base) 395/395
(100 %)
1 diff
(99.8 %id)
AW275777 normal squamous epithelium, tongue .i-u 115 to 502 440 to 53   AAA Possibly primed on the genome, locally A rich (37/37 A in genome downstream of last aligned base) 388/388
(100 %)
1 diff
(99.8 %id)
BM802941 duodenal adenocarcinoma, cell line, small intestine .i-u 518 to 1335 96 to 919   tiling clone,   908/972
(93 %)
20 diff
(98.0 %id)
BY797288 eye .i-u 530 to 1033 1 to 504       504/504
(100 %)
0 diff
(100 %id)
BX501343 Liver .j-u 1 to 729 1 to 728 exact tiling clone,   728/728
(100 %)
2 diff
(99.8 %id)
BY994795   .l-u 1 to 643 678 to 36 exact tiling clone, Submitted on the opposite strand 643/703
(91 %)
0 diff
(100 %id)
BE221654 malignant melanoma, metastatic to lymphnode, skin .l-u 164 to 637 474 to 1       474/474
(100 %)
0 diff
(100 %id)
BP229825 brain .m 1 to 583 1 to 581 K31T A36P N51D tiling clone,   581/581
(100 %)
9 diff
(98.5 %id)
DB182866 liver, tumor tissue .n 1 to 567 2 to 569 exact tiling clone, capped   568/568
(100 %)
1 diff
(99.9 %id)
DB451704 testis .o 1 to 499 1 to 500 exact tiling clone,   500/500
(100 %)
3 diff
(99.4 %id)
BE163878 head_neck .p-u 1 to 309 331 to 19 L40C C41V I42Y C43I L44V ... tiling clone, Submitted on the opposite strand 313/331
(94 %)
0 diff
(100 %id)
BE163882 head_neck .p-u 22 to 318 14 to 311 exact tiling clone,   298/319
(93 %)
8 diff
(97.5 %id)
BF838288 head_neck Gene C10orf119, variant not shown         This clone was ignored    
DB298959 cerebellum Gene C10orf119, variant not shown         This clone was ignored    
DA098892 cerebellum Gene C10orf119, variant not shown       capped This clone was ignored    
DA184808 amygdala Gene C10orf119, variant not shown       capped This clone was ignored    
AL536159 brain, fetal brain Gene C10orf119, variant not shown         This clone was ignored    
AL566212 brain, fetal brain Gene C10orf119, variant not shown         This clone was ignored    
BP231513 muscle Gene C10orf119, variant not shown         Suspected internal deletion, this clone was ignored    
BM917738 blood, natural killer cells, cell line Gene C10orf119, variant not shown              
BQ929053 carcinoma, cell line, Prostate Gene C10orf119, variant not shown         Suspected internal deletion, this clone was ignored    
DA644821   Gene C10orf119, variant not shown       capped Suspected internal deletion, suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i-u, .j-u, .k-u, .l-u, .m, .n, .o, .p-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI